Home/Atriva Therapeutics/Prof. Dr. Oliver Planz
PD

Prof. Dr. Oliver Planz

Co-founder & Chief Scientific Officer

Atriva Therapeutics

Atriva Therapeutics Pipeline

DrugIndicationPhase
Zapnometinib (ATR-002)InfluenzaPhase 2